MYC and cancer: Notably, MYC activation of the PD-L1 gene appears to require greater MYC promoter binding than genes involved in normal cell growth; hence, they may constitute promoters invaded by oncogenic MYC levels and be especially sensitive to MYC withdrawal.44 Through suppressing immune surveillance against tumor cells, TRMT61A may impact cancer immunoediting.